http://www.fda.gov/cder/orange/appendix_a.txt 2, BUTABARBITAL SODIUM SARISOL, BUTABARBITAL SODIUM APPENDIX A PRODUCT NAME INDEX SATRIC, METRONIDAZOLE SCABENE, LINDANE SCANDONEST L, LEVONORDEFRIN SCANDONEST PLAIN, MEPIVACAINE HYDROCHLORIDE SCLEROSOL, TALC SCRUBTEAM SURGICAL SPONGEBRUSH, HEXACHLOROPHENE SEASONALE, ETHINYL ESTRADIOL SECOBARBITAL SODIUM, SECOBARBITAL SODIUM SECONAL SODIUM, SECOBARBITAL SODIUM SECREFLO, SECRETIN...
Prescription and Over-the-Counter Drug Product List: 6/2003 >D> AP + WYETH AYERST 5,000 UNITS/VIAL N17055 001 JUN DISC >A> @ 5,000 UNITS/VIAL N17055 001 JUN DISC >D> AP + 10,000 UNITS/VIAL N17055 002 JUN DISC >A> @ 10,000 UNITS/VIAL N17055 002 JUN DISC GUANABENZ ACETATE TABLET; ORAL GUANABENZ ACETATE >D> AB WATSON LABS EQ 8MG BASE N74025 002 FEB 28, 1994 JUN CRLD >A> AB + EQ 8MG BASE N74025 002 FEB 28, 1994 JUN CRLD >D> WYTENSIN ...
author: AUTHOR
Prescription and OTC Drug Product List 2/2001 PEDIATRIC - ADD - @ 10MG;100MG N74080 001 - ADD - + ASTRAZENECA /1VIL;0.02MG/VIAL;0.001MG/VIAL; - ADD - MAR 25, 1994 - ADD - 5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL; - ADD - @ 25MG;100MG N74080 002 - ADD - 17MG/VIAL;0.2MG/VIAL; - ADD - MAR 25, 1994 - ADD - EQ 1MG BASE/VIAL;1.4MG/VIAL; - ADD - @ 25MG;250MG N74080 003 - ADD - EQ 1.2MG BASE/VIAL;0.7MG/VIAL; - ADD - MAR 25, 1994 - ADD - 7MG...
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt AMIODARONE HCL 3506 24-Apr-79 BAXTER ONCOLOGY GMBH IFOSFAMIDE 3507 27-Apr-79 GEDEON RICHTER LTD VINCRISTINE SULFATE 3513 08-Mar-79 FABBRICA ITALIANI SINTETICI SPA FUROSEMIDE 3516 30-Mar-79 DINAMITE DIPHARMA SPA TRIAMTERENE USP XIX/BP '73 3524 08-Feb-79 DINAMITE DIPHARMA SPA "CYPROHEPTADINE HCL, USP" 3529 30-May-79 AVENTIS PHARMA SA PREDNISOLONE ACETATE 3531 14-Mar-79 "NISSHIN...
FDA Drug Approvals List December 1999 Active Ingredient(s): DILTIAZEM HYDROCHLORIDE OTC/RX Status: RX Original Abbreviated Application # 075406 Approval Date: 15-DEC-99 Trade Name: NORGESTREL AND ETHINYL ESTRADIOL Dosage Form: TABLET Applicant: SCS PHARMACEUTICALS Active Ingredient(s): NORGESTREL; ETHINYL ESTRADIOL OTC/RX Status: RX Original Abbreviated Application # 040262 Approval Date: 15-DEC-99 Trade Name: LEUCOVORIN...
Prescription and OTC Drug Product List 6/2002 PEDIATRIC -A- + AAIPHARMA 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL; 5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17 MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/V IAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL N18920 001 SEP 21, 2000 JUL CAHN -D- + NEOSAN PHARMS 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL; 5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17 MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/V IAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL...
IL135 R x Only (Hydrocortisone Acetate Cream USP, 1%) DESCRIPTION: CARMOL ® HC is intended for topical administrationHydrocortisone Acetate USP, in a water- washable vanishing cream base containing urea (10%), purified water, stearic acid, propylene glycol, isopropyl myristate, isopropyl palmitate, PPG- 26 oleate,...
author: Bradley
IL135 page 1
author: Bradley
http://www.bradpharm.com/PressreleaseSecuritiesParamount.pdf page 1
author: Maureen Krsulic
A to Z List - Medication Information A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z - A Abacavir Abacavir, lamivudine, zidovudine Acyclovir Alendronate Allopurinol Amifostine Amitriptyline Amlodipine Amoxicillin Amoxicillin / clavulanic acid Amphotericin B Ampicillin Amprenavir Anti-thymocyte globulin Asparaginase Atenolol Atovaquone Atracurium Azithromycin...
author: St. Jude Children's Research Hospital
http://www.fda.gov/cder/dmf/xls/4Q2003ACTIVETYPE2EXCEL.xls PHYTONADIONE, USP (VITAMIN K1) MANUFACTURED IN TOKYO, JAPAN AVENTIS PHARMA SA PREDNISOLONE USP MANUFACTURED IN PUTEAUX, FRANCE MAKOR CHEMICALS LTD DACTINOMYCIN CHUGAI PHARMACEUTICAL CO LTD SUCRALFATE CARAFATE TM GANES CHEMICALS INC PROPOXYPHENE NAPSYLATE, BULK FORM-MANUF CARLSTADT, NJ FACILITY LUSOCHIMICA S P A ISOXSUPRINE HYDROCHLORIDE FRANCO INDIAN PHARMACEUTICALS PVT LTD...
Paddock Laboratories, Inc. - Master Product List USP (Enteric-Coated Yellow) OTC 0004-01 0004-10 0004-11 5 mg - 100's 5 mg - 1000's 5 mg - U/D 100's - - - [C]--PRODUCTS-- Rx or OTC NDC 0574- Strength / Size MSDS Secundum Artem Issues Biblio- graphy Listing CASTOR OIL USP OTC 3312-02 2 oz Vol 3 No 4 ; Vol 5 No 3 ; Vol 10 No 2 - COLISTIN SULFATE USP POWDER Rx 0417-01 1 BU ** - - COLLODION, FLEXIBLE USP OTC 0560-04 4 oz - - - COLOCORT...
http://www.paddocklabs.com/images/PadSec7-1.pdf page 5
http://www.paddocklabs.com/forms/secundum/volume_6_1.pdf Loyd VAcetate 20 Labetalol Hydrochloride 40 Metoprolol Tartrate 10 Verapamil Hydrochloride 50 Spironolactone and Hydrochlorothiazide 5/ 5 STABILITY OF EXTEMPORANEOUS FORMULATIONS...
http://www.paddocklabs.com/forms/secundum/volume_8_4.pdf Secundum Artem VOLUME 8 NUMBER 4 Current & Practical Compounding Information for the Pharmacist
http://www.MTRA.com/home/bioanalytical_listing.pdf Bioanalytical Assay List AAI International, Inc. 2320 Scientific Park Drive, Wilmington, NC 28405 USA Phone: 1.800.575.4AAI (4224) Fax: 1.910.815.2300 Bioanalytical Laboratories 12400 Shawnee Mission Parkway, Shawnee Kansas 66216 (P: 913.248.3000 / F: 913.248.3106) Wegenerstrasse 13, ...
kud70e1.tmp ?4cIlreath 30 Bor$ ght Avenue Kenilworth, NJ 07033 Gentlemn: Reference is made to your supplement dated May 5, 1980 regarding your abbreviated new drug application submitted pursuant to Section 505( b) of the Federal Food, Drug, and Cosmetic Act for E# foam (Hydrocortisone Acetate %wosol Foam, 1%}Hydrocortisone ...
author: fda
http://www.fda.gov/cder/da/ddpa92.wpd 73 085 FLUOCINONIDE NMC FLUOCINONIDE 02 14 92 (CREAM) GLENDALE, NY 0.05% 11385 (CORTICOSTEROID) 72 651 NIFEDIPINE NOVOPHARM NIFEDIPINE 02 19 92 (CAPSULE) SCARBOROUGH 10MG ONTARIO, CANADA (CALCIUM ION INFLUX INHIBITOR) 72 652* ALBUTEROL SULFATE DEY ALBUTEROL SULFATE 02 21 92 (SOLUTION/INHALATION) NAPA, CA EQ 0.083% BASE 94558 (BRONCHODILATOR) 72 646 SILPHEN SILARX DIPHENHYDRAMINE...
510(k)s Final Decisions Rendered FDA Home Page | CDRH Home Page | Search | CDRH A-Z Index | Contact CDRH 510(k)s Final Decisions Rendered for May 1999 Some of the documents on this section of the CDRH Website are available only in PDF format and may not be accessible to those with certain disabilities
author: OSM/DID
Treatment: Diagnosis and Treatment of Skin Disorders: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
Worthington Malate Dehydrogenase Malate Dehydrogenases, Biochim Biophys Acta 707, 133, 1982 - MŸller, J., Gorisch, H., and Parkhurst, L.: Dissociation of Mitochondrial Malate Dehydrogenase, Biochim Biophys Acta 787, 258, 1984 - Nabi, A., and Worsfold, P.: Indirect Flow-Injection Assays for Glucose-6-Phosphate Dehydrogenase/Glucose-6-Phosphate and Malate Dehydrogenase/L-Malate Using Immobilized Bacterial...
http://www-clinpharm.medschl.cam.ac.uk/pages/publications/documents/Clin_Med_2005_5_55.pdf f & 7 In two practices, we investigated whether Na + loading of the tension was accepted if patients were receiving treatment, and/ or J ° * i + u i i J I U II °° ^ r ° distal tubule would unmask hypokalaemia in apparently had three blood pressure readings > 140/ 90 mmHg.
Community-Acquired Pneumonia (CAP) Year 2003 Antibiotic Selection and Management Update - Trouble navigating this siteurea nitrogen, and altered level of consciousness are predictive of more serious disease, as are age and acquisition of CAP in a nursing home environment
510(k)s Final Decisions Rendered FDA Home Page | CDRH Home Page | Search | CDRH A-Z Index | Contact CDRH 510(k)s Final Decisions Rendered for October 1999 Some of the documents on this section of the CDRH Website are available only in PDF format and may not be accessible to those with certain disabilities
author: OSM/DID
510(k)s Final Decisions Rendered FDA Home Page | CDRH Home Page | Search | CDRH A-Z Index | Contact CDRH 510(k)s Final Decisions Rendered for September 2000 Some of the documents on this section of the CDRH Website are available only in PDF format and may not be accessible to those with certain disabilities
author: OSM/DID
